Charité - Universitätsmedizin Berlin

High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers (2022) Kokolakis G, Kreis G, Falqués M, Aparici M, Sondermann W Journal article Fibrin-targeting molecular MRI in inflammatory CNS disorders (2022) Lohmeier J, Silva R, Tietze A, Taupitz M, Kaneko T, Pruss H, Paul F, et al. Journal article Prostate158 - An expert-annotated 3T MRI dataset and algorithm for prostate cancer detection (2022) Adams LC, Makowski MR, Engel G, Rattunde M, Busch F, Asbach P, Niehues SM, et al. Journal article Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial (2022) Lechner K, Von Schacky C, Scherr J, Lorenz E, Bock M, Lechner B, Haller B, et al. Journal article Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry (2022) Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Schuetz C, Kallinich T, et al. Conference contribution Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial (2022) Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Rech J, Burmester G, et al. Conference contribution Accelerating AxSpA Diagnosis: Exploring At-home Self-sampling, Symptom Checkers, Medical Student-visits and Asynchronous Reportbased Assessment (2022) Labinsky H, Von Rohr S, Raimondo MG, Vogt E, Horstmann B, Gehring I, Rojas-Restrepo J, et al. Conference contribution Generalization of a deep learning model for HER2 status predictions on H&E-stained whole slide images derived from 3 neoadjuvant clinical studies (2022) Haegele M, Mueller KR, Denkert C, Schneeweiss A, Sinn BV, Untch M, Van Mackelenbergh MT, et al. Conference contribution When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study (2022) Hampl M, Jaeger A, Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution